Bleomycin and 5-fluorouracil

PreclinicalSmall molecule

Bleomycin and 5-fluorouracil is one of 13 small molecule programs targeting Plantar Wart. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Plantar WartActive, not recruiting

Plantar WartPreclinical

Active, not recruiting

Competition

Competitive Landscape

23 competitors in Plantar Wart

#DrugCompanyPhaseTrials

Aldara

BBausch Health Americas, Inc.

Approved

1 2

Zovirax

BBp Consulting, Inc

Approved

1 3

CRYOTHERAPY

AAssistance Publique - Hôpitaux de Paris

Approved

1 4

Salicylate

AAssistance Publique - Hôpitaux de Paris

Approved

1 5

Inomax

MMallinckrodt

Phase 2

1 6

Salicylic Acid

HHadassah Medical Organization

Phase 3

1 7

Blenoxane

Bristol-Myers Squibb

Preclinical

3 8

Potassium Hydroxide

SSohag University

Phase 3

1 9

Intralesional Acyclovir

RRiphah International University

Phase 3

1 10

Adrucil

EElorac, Inc.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Plantar Wart1 trial

Intralesional Treatment of Plantar Wart

Unknown status·SSohag University·N/A·NCT05057663·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Bleomycin and 5-fluorouracil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bleomycin and 5-fluorouracil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bleomycin and 5-fluorouracil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sohag University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSohag University

Bleomycin and 5-fluorouracil

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Plantar Wart1 trial

References

Drug Info

Quick Facts

Related News